A comparative study of intraperitoneal carboplatin versus intravenous carboplatin with intravenous cyclophosphamide in both arms as initial chemotherapy for stage III ovarian cancer.
Polyzos A, Tsavaris N, Kosmas C, Giannikos L, Katsikas M, Kalahanis N, Karatzas G, Christodoulou K, Giannakopoulos K, Stamatiadis D, Katsilambros N.
Polyzos A, et al.
Oncology. 1999;56(4):291-6. doi: 10.1159/000011980.
Oncology. 1999.
PMID: 10343192
Clinical Trial.
In the past we have shown that intraperitoneal (IP) CBP administration is a safe and effective treatment for OC [Polyzos et al: Proc Am Assoc Cancer Res 1990;31: 1120]. ...The favorable results on survival demonstrated in studies with IP C administration in patients …
In the past we have shown that intraperitoneal (IP) CBP administration is a safe and effective treatment for OC [Polyzos et al …